| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Olmesartin medoxomil + hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| olmésartan médoxomil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olmesartan medoxomil 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing amlodipine and olmesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| médicament contenant olmésartan médoxomil et hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing amlodipine and hydrochlorothiazide and olmesartan medoxomil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olmesartan medoxomil 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
Has precise active ingredient |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has precise active ingredient |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartin medoxomil 40mg/hydrochlorothiazide 25mg tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Olmesartan medoxomil 20 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 5 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Olmesartan medoxomil 40 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
Has precise active ingredient |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing chlortalidone and olmesartan medoxomil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only chlortalidone and olmesartan medoxomil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing chlortalidone and olmesartan medoxomil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only chlortalidone and olmesartan medoxomil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only cilnidipine and olmesartan medoxomil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing cilnidipine and olmesartan medoxomil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only cilnidipine and olmesartan medoxomil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing cilnidipine and olmesartan medoxomil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cilnidipine 10 mg and olmesartan medoxomil 20 mg oral tablet |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cilnidipine 10 mg and olmesartan medoxomil 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Olmesartan medoxomil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]